isoxazoles has been researched along with cyclosporine in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 77 (50.66) | 18.2507 |
2000's | 48 (31.58) | 29.6817 |
2010's | 26 (17.11) | 24.3611 |
2020's | 1 (0.66) | 2.80 |
Authors | Studies |
---|---|
Chong, A; Foster, P; Jensik, S; McChesney, L; Mital, D; Sankary, H; Shen, J; Short, J; Xiao, F; Yang, J | 1 |
Bartlett, RR; Coupland, SE; Hoffmann, F; Karow, AC; Krause, L; Lehmann, M | 1 |
Achilleos, O; Buckels, JA; Candinas, D; D'Silva, M; Dalgic, A; Lee, SJ; Mayer, AD; McMaster, P | 1 |
Kahan, BD | 1 |
Berry, GJ; Billingham, ME; Gregory, CR; Huang, X; Morris, RE; Rowan, R; Shorthouse, R | 1 |
Heeg, K; Lang, R; Wagner, H | 1 |
Lin, Y; Sobis, H; Vandeputte, M; Waer, M | 3 |
Cao, W; Huang, X; Morris, RE; Shorthouse, RA; Zheng, B | 1 |
Lang, LS; Robertson, SM | 1 |
Chong, AS; Foster, P; Frieders, D; Koukoulis, G; McChesney, L; Sankary, H; Williams, JW; Xiao, F; Yang, J | 1 |
Bitter-Suermann, H; Lee, T; MacAuley, MA; MacDonald, AS; McAlister, VC; Sabr, K | 1 |
Bartlett, RR; Coupland, SE; Hoffmann, F; Karow, AC; Klebe, S; Krause, L; Kruse, H | 1 |
Foster, PF; Haklin, M; McChesney, LP; Sankary, HN; Sharma, S; Williams, JW; Xiao, F | 1 |
Chong, A; Foster, P; Frieders, D; McChesney, L; Sankary, H; Williams, JM; Williams, JW; Xiao, F | 1 |
Kearns, H; McDonald, AS; Wright, JR | 1 |
Bitter-Suermann, H; He, G; Lee, TD; MacDonald, AS; McAlister, VC; Theal, M; Wright, J | 1 |
Lang, LS; Mellon, J; Niederkorn, JY; Robertson, SM; Ross, J | 1 |
Chong, AS; Clardy, C; Foster, P; McChesney, L; Sankary, H; Williams, JW; Xiao, F | 1 |
Connolly, KM; Noel, LS; Smith-Oliver, T; Stimpson, SS; Yarnall, DP | 1 |
Chong, AS; Finnegan, A; Foster, P; Gebel, H; Jiang, X; Sankary, HN; Williams, JW | 1 |
Bartlett, R; Chong, A; Foster, PF; Sankary, HN; Sharma, S; Williams, JW; Xiao, F | 1 |
Chong, AS; Finnegan, A; Foster, P; Gebel, H; Jiang, XL; Petraitis, EE; Sankary, HN; Williams, JW | 1 |
Bartlett, RR; Schorlemmer, HU; Seiler, FR | 1 |
Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Rafael, E; Sundberg, B; Tibell, A; Wallgren, AC; Wennberg, L; Zhu, S | 2 |
Lin, Y; Vandeputte, M; Waer, M | 4 |
Furst, DE | 1 |
Blinder, L; Chong, AS; Foster, P; Sankary, H; Shen, J; Williams, JW; Xiao, F | 1 |
Blinder, HL; Chong, A; Foster, P; Liu, W; McChesney, L; Mital, D; Sankary, H; Shen, J; Williams, JW; Xiao, F | 1 |
Kemp, E; Lillevang, S; Nielsen, B; Salomon, S; Steinbrüchel, DA | 1 |
Adams, B; Berry, GJ; Brazelton, T; Morris, RE; Reichenspurner, H; Reitz, BA; Shorthouse, R; Soni, V | 1 |
Gregory, CR; Griffey, SM; Levitski, RE; Lirtzman, RA; Morris, RE; Patz, JD; Yeh, LS | 1 |
Halloran, PF | 1 |
Blinder, L; Chong, AS; Foster, P; Sankary, H; Shen, J; Wei, L; Williams, J; Xiao, F | 1 |
Coupland, SE; Hoffmann, F; Klebe, S; Krause, L | 1 |
Gregory, CR; Griffey, SM; Lecouteur, RA; Morris, RE; Yeh, LS | 1 |
Brauer, R; Henzgen, S; Katenkamp, D; Petrow, PK; Thoss, K | 1 |
Foster, PF; Kociss, K; Sankary, HN; Shen, J; Williams, JW; Xiao, F | 1 |
Kurrle, R; Schorlemmer, HU | 4 |
Kurrle, R; Ruuth, E; Schorlemmer, HU; Schwab, W | 1 |
Lin, Y; Waer, M | 2 |
Chong, AS; Foster, P; Gebel, H; Guo, Z; Jensik, SC; McChesney, L; Mital, D; Sankary, HN; Shen, J; Williams, JW | 1 |
Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Rafael, E; Sundberg, B; Wennberg, L; Zhu, S | 1 |
d'Atri, G; Di Pierro, F; Leoni, F; Marcucci, F | 1 |
Chong, AS; Foster, P; Guo, Z; Jensik, S; McChesney, L; Mital, D; Sankary, H; Shen, J; Tian, Y; Williams, JW; Yin, D | 1 |
Chong, AS; Foster, PF; Fu, Z; Guo, Z; Jensik, S; McChesney, LP; Mital, D; Sankary, HN; Shen, J; Tian, Y; Williams, JW | 1 |
Biberfeld, P; Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Morris, RE; Rafael, E; Söderlund, J; Tibell, A; Wennberg, L; Zhu, S | 1 |
Blinder, L; Chong, AS; Foster, P; Karademir, S; Sankary, H; Shen, J; Short, J; Williams, JW | 1 |
Gregory, CR; Griffey, SM; Hou, SM; Lecouter, RA; Morris, RE; Yeh, LS | 1 |
Blinder, L; Chong, AS; Ma, LL; Shen, J; Williams, JW; Yin, DP | 1 |
Ji, P; Lin, Y; Vandeputte, M; Waer, M; Xia, G | 1 |
Ekberg, H; Hedlund, G; Ostraat, O; Qi, ZQ; Tufveson, G | 1 |
Gregory, CR | 1 |
Kitada, M; Kiuchi, M; Nakamura, H; Nakasa, H; Ohmori, S; Ono, S; Tsutsui, M | 1 |
Bonham, CA; Gerber, DA; Thomson, AW | 1 |
Horn, HC; Jensen, JE; Johansen, A; Kemp, E; Nielsen, B | 1 |
Lindner, JK; Zantl, N | 1 |
Kurrle, R; Ruuth, E; Schorlemmer, HU | 1 |
Blinder, L; Chong, AS; Ma, LL; Sankary, H; Shen, J; Williams, JW; Yin, D | 1 |
Blinder, L; Chong, AS; Foster, P; Huang, W; Jensik, S; Liu, W; McChesney, L; Mital, D; Sankary, H; Shen, J; Williams, JW; Xiao, F | 1 |
Ekberg, H; Qi, Z; Simanaitis, M | 1 |
Ekberg, H; Qi, Z | 1 |
Gregory, CR; Hou, SM; Jeng, CR; Lai, YC; Lui, LT; Yeh, LS | 1 |
Dimitrijevic, M; Glisic, B; Obradovic, S; Pejnovic, N; Popovic, M; Popovic, R; Stefanovic, D | 1 |
Gross, WL | 1 |
Berry, GJ; Boeke, K; Christians, U; Gummert, JF; Hausen, B; Morris, RE | 1 |
Morris, RE; Sherwood, SW; Silva, HT; Slauson, SD | 1 |
Bari, S; Groth, CG; Korsgren, O; Song, Z; Sundberg, B; Wennberg, L; Wijkström, M; Zhang, J | 1 |
Bari, S; Bennet, W; Groth, CG; Korsgren, O; Nava, S; Song, Z; Sundberg, B; Wennberg, L; Zhang, J | 2 |
Craigmill, AL; Gregory, CR; Kyles, AE | 1 |
Dambrin, C; Klupp, J; Morris, RE | 1 |
Ambach, A; Konstandin, M; Meuer, SC; Samstag, Y; Saunus, J; Wesselborg, S | 1 |
Achilleos, O; Candinas, D; D'Silva, M; Dalgic, A; Lee, SJ; Mayer, AD; McMaster, P; Miki, C | 1 |
Kremer, JM | 1 |
Bouillon, R; Gysemans, C; Laureys, J; Mathieu, C; Waer, M | 1 |
duToit, DF; Lyners, R; Mattysen, J; Muller, CJ; Muller, N; Page, BJ | 1 |
Albert, R; Andersen, E; Floersheim, P; Hungerford, V; Papageorgiou, C; Schreier, MH; Zurini, M | 1 |
O'Dell, J | 1 |
Remer, CF; Wallace, DJ; Weisman, MH | 1 |
Bickerstaff, A; Gordillo, G; Knight, DA; Orosz, CG; Orosz, K; Waldman, WJ | 1 |
Pisetsky, DS; St Clair, EW | 1 |
Flores, RH; Hochberg, MC; Tracy, JK | 1 |
Drosos, AA | 1 |
Fujita, M; Furukawa, H; Jin, MB; Mino, K; Nakayama, M; Ogata, T; Shimamura, T; Suzuki, T; Taniguchi, M; Todo, S | 1 |
Groth, CG; Hagberg, A; Korsgren, O; Krook, H; Song, Z; Wennberg, L | 1 |
Gross, WL; Schnabel, A | 1 |
Bernsteen, L; Gregory, CR; Griffey, SM; Kyles, AE; Lilja, HS; Morris, RE; Pierce, J | 1 |
Balabanova, RM | 1 |
Billingham, M; Brazelton, T; Briffa, NP; Chan, J; Morris, RE; Shorthouse, R; Silva, H | 1 |
Burmester, GR; Müller-Ladner, U; Rüther, W | 1 |
Emery, P; Suarez-Almazor, M | 1 |
Gladman, DD | 1 |
Heath, M; Raugi, GJ | 1 |
Assimakopoulos, D; Bai, M; Drosos, AA; Papazisi, D; Voulgari, PV; Zagorianakou, P | 1 |
Fath, R | 1 |
Burmester, GR | 1 |
Casadio, F; Corti, B; Croci, S; D'Errico Grigioni, A; Grigioni, WF; Landuzzi, L; Lollini, PL | 1 |
Ejsing, TB; Linnet, K; Pedersen, AD | 1 |
Andrianakos, A; Antoniades, C; Charalambopoulos, D; Karanikolas, G; Katsilambros, N | 1 |
Rintala, JM; Rintala, SE; Savikko, J; von Willebrand, E | 3 |
Badgwell, C; Rosen, T | 1 |
Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 1 |
Tłustochowicz, W | 1 |
McHugh, NJ; Soriano, ER | 1 |
Deuse, T; Hoyt, G; Koyanagi, T; Robbins, RC; Schrepfer, S | 1 |
Bagot, M; Claudepierre, P | 1 |
Andrianakos, A; Charalambopoulos, D; Karanikolas, G; Karras, D; Kaskani, E; Rapti, A; Sfikakis, PP; Vaiopoulos, G | 1 |
Gergely, P; Poór, G | 1 |
Mimori, T; Yukawa, N | 1 |
Mimori, T | 1 |
Chen, X; Huang, P; Luo, S; Tu, G; Yang, G; Yao, Z | 1 |
Förger, F; Østensen, M | 1 |
Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E | 1 |
Dickenmann, M; Egli, A; Hirsch, HH; Köhli, S | 1 |
Bonsmann, G; Kuhn, A; Ruland, V | 1 |
First, MR; Fitzsimmons, W; Guasch, A; Holman, J; Roy-Chaudhury, P; Woodle, ES | 1 |
Matuszewska, A; Misterska-Skóra, M; Wiland, P | 1 |
Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
Kiss, CG; Kiss, E; Poór, G | 1 |
Gao, E; He, B; Koch, W; Lau, WB; Ma, XL; Pu, J; Shan, P; Wang, X; Wang, Y; Yuan, A | 1 |
Lei, T; Liu, G; Peng, J; Sun, C; Wang, R; Wu, T; Xu, K; Zhang, L; Zhao, Y | 1 |
Lubrano, E; Scarpa, R | 1 |
Miller, AV; Ranatunga, SK | 1 |
Allahyari, M; Farimani, ES; Hadizadeh, F; Moalem, SA; Rameshrad, M | 1 |
Chen, D; Hu, X; Li, L; Ma, Y; Mao, Z; Mei, C; Sun, L; Xie, G; Xu, C; Xu, J; Yang, L; Ye, C; Zhao, X | 1 |
Dodam, JR; Nafe, LA; Reinero, CR | 1 |
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
Foley, P; Kelly, JB; Strober, BE | 1 |
Chan, TM | 1 |
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
Frambach, Y; Gerdes, S; Jacobi, A; Mössner, R; Philipp, S; Weyergraf, AJ; Wilsmann-Theis, D | 1 |
Bitterman, H; Cohen, AD; Cohen, Y; Dreiher, J; Feldhamer, I; Greenberg-Dotan, S; Hammerman, A; Harman-Boehm, I; Moser, H; Shalom, G; Zisman, D | 1 |
Moroni, G; Ponticelli, C | 1 |
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
Fang, C; He, Y; Huang, C; Li, J; Lin, Z; Zhan, S; Zhou, D | 1 |
Forte, M; Šileikytė, J | 1 |
Craig, JC; Hodson, EM; Willis, NS; Wong, SC | 1 |
Al Habeeb, A; Chan, AW; Chang, J; Kassar, R; Lilly, LB; Rotstein, C | 1 |
Archer, TM; Mackin, AJ; Thomason, JM; Wills, RW | 1 |
Kowdley, KV; Shah, RA | 1 |
37 review(s) available for isoxazoles and cyclosporine
Article | Year |
---|---|
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus | 1994 |
Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard.
Topics: Absorption; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Mechlorethamine; Tissue Distribution | 1995 |
Molecular mechanisms of new immunosuppressants.
Topics: Amino Acid Isomerases; B-Lymphocytes; Biphenyl Compounds; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Isoxazoles; Leflunomide; Mycophenolic Acid; Oxidoreductases; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Polyenes; Purines; Pyrimidines; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; T-Lymphocytes; Tacrolimus | 1996 |
Immunosuppressive approaches to the prevention of graft vascular disease.
Topics: Coronary Disease; Cyclosporine; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Postoperative Complications; Sirolimus; Tacrolimus | 1998 |
Immunosuppressive agents: recent developments in molecular action and clinical application.
Topics: Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Models, Biological; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; T-Lymphocytes; Tacrolimus; Transplantation Immunology | 1998 |
New concepts in treatment protocols for severe systemic vasculitis.
Topics: Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Vasculitis | 1999 |
Pharmacodynamics of immunosuppressive drugs.
Topics: Animals; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Sirolimus; Tacrolimus | 2000 |
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine | 2001 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Maximum Tolerated Dose; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2001 |
Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.
Topics: Animals; Arthritis, Rheumatoid; Cyclosporine; Cytokines; Gene Expression Regulation; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mitogen-Activated Protein Kinases; Mycophenolic Acid; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Sirolimus; Tacrolimus | 2002 |
[Current concepts of pharmacotherapy in rheumatoid arthritis].
Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Cyclophosphamide; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Ibuprofen; Immunosuppressive Agents; Isoxazoles; Ketoprofen; Leflunomide; Male; Methotrexate; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfasalazine; Time Factors | 2003 |
[Diagnosis and therapy of rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty; Cyclooxygenase Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatoid Factor; Sulfasalazine | 2004 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Psoriatic arthritis.
Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Laryngeal involvement in rheumatoid arthritis.
Topics: Aged; Anti-Inflammatory Agents; Arytenoid Cartilage; Cricoid Cartilage; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Joints; Laryngeal Diseases; Leflunomide; Methylprednisolone; Prednisone; Rheumatoid Nodule; Treatment Outcome | 2005 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide | 2007 |
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Disease Progression; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Radiography; Remission Induction; Sulfasalazine | 2007 |
[Rational therapeutic approach in rheumatoid arthritis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isoxazoles; Joint Prosthesis; Leflunomide; Methotrexate; Prostheses and Implants; Sulfasalazine | 2006 |
Conventional therapy of psoriatic arthritis: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome | 2007 |
[New ways in the management of rheumatoid arthritis in Hungary].
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Topics: Adult; Alkylating Agents; Calcineurin Inhibitors; China; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tacrolimus | 2012 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Immunosuppression in pregnant women with systemic lupus erythematosus.
Topics: Contraindications; Cyclosporine; Female; Glucocorticoids; Humans; Hypertension; Immunosuppression Therapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Maternal Exposure; Mycophenolic Acid; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Withholding Treatment | 2015 |
Shutting down the pore: The search for small molecule inhibitors of the mitochondrial permeability transition.
Topics: Anilides; Benzamidines; Cyclosporine; Drug Design; High-Throughput Screening Assays; Isoxazoles; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Oximes; Peptides, Cyclic; Quinolinium Compounds; Secosteroids; Structure-Activity Relationship | 2016 |
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dexamethasone; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Isoxazoles; Leflunomide; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Randomized Controlled Trials as Topic; Remission Induction | 2016 |
Current and potential treatments for primary biliary cholangitis.
Topics: Benzothiazoles; Bezafibrate; Bile Acids and Salts; Budesonide; Case-Control Studies; Chenodeoxycholic Acid; Cholagogues and Choleretics; Clinical Trials as Topic; Cyclosporine; Disease Progression; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Liver Cirrhosis, Biliary; Liver Transplantation; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Rituximab; Treatment Outcome; United States; United States Food and Drug Administration; Ursodeoxycholic Acid | 2020 |
5 trial(s) available for isoxazoles and cyclosporine
Article | Year |
---|---|
Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Levamisole; Male; Methotrexate; Middle Aged | 1998 |
Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Joints; Leflunomide; Severity of Illness Index; Treatment Outcome | 2006 |
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2008 |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.
Topics: Algorithms; Alkynes; Creatinine; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Mycophenolic Acid; Nitriles; Patient Compliance; Polyomavirus Infections; Sirolimus; Tacrolimus; Time Factors; Viral Load | 2010 |
Effects of immunosuppressive agents on the hemostatic system in normal dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azathioprine; Blood Coagulation; Blood Platelets; Creatinine; Cross-Over Studies; Cyclosporine; Dogs; Female; Hemostasis; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Platelet Aggregation; Platelet Count; Prednisone; Thromboxane B2 | 2018 |
110 other study(ies) available for isoxazoles and cyclosporine
Article | Year |
---|---|
Pharmacologically induced regression of chronic transplant rejection.
Topics: Animals; Cell Division; Cyclosporine; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Isoantibodies; Isoxazoles; Leflunomide; Male; Muscle, Smooth; Rats; Rats, Inbred F344; Rats, Inbred Lew | 1995 |
Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporin A and leflunomide.
Topics: Animals; Antibodies, Monoclonal; CD4 Antigens; Corneal Transplantation; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous | 1995 |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous | 1994 |
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Occlusion, Vascular; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus; Tunica Intima | 1995 |
Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Leflunomide blocks clonal T cell expansion yet allows production of lymphokines and manifestation of T cell-mediated shock.
Topics: Animals; Cell Cycle; Cell Division; Cells, Cultured; Cyclosporine; Flow Cytometry; Interleukin-2; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Superantigens; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1995 |
Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
Topics: Animals; Antibodies, Heterophile; Antibody Formation; Complement System Proteins; Cricetinae; Cyclosporine; Cytotoxicity, Immunologic; Flow Cytometry; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Strains; Rats, Nude; Transplantation, Heterologous | 1995 |
Leflunomide (HWA 486) and its analog suppress T- and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening afte
Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arteries; B-Lymphocytes; Catheterization; Crotonates; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Toluidines; Transplantation, Homologous; Tunica Intima | 1995 |
Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
Topics: Administration, Oral; Administration, Topical; Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Eye Proteins; Freund's Adjuvant; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Retina; Uveitis | 1994 |
Leflunomide controls rejection in hamster to rat cardiac xenografts.
Topics: Animals; Cricetinae; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Lew; Transplantation, Heterologous | 1994 |
Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
Topics: Animals; Cricetinae; Cyclosporine; Drug Synergism; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Time Factors; Transplantation, Heterologous | 1994 |
Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
Topics: Animals; Antibodies, Heterophile; Cricetinae; Cyclosporine; Cytotoxicity, Immunologic; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Heterologous | 1994 |
Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
Topics: Animals; Aorta, Thoracic; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Leflunomide; Muscle, Smooth, Vascular; Rats; Rats, Inbred Lew; Rats, Inbred WF; Transplantation, Homologous; Tunica Intima | 1994 |
Leflunomide therapy following penetrating keratoplasty in the rat.
Topics: Administration, Oral; Animals; Cornea; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Keratoplasty, Penetrating; Leflunomide; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1994 |
An evaluation of leflunomide in the canine renal transplantation model.
Topics: Administration, Oral; Animals; Creatinine; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Female; Graft Survival; Immunosuppressive Agents; Injections, Intravenous; Isoxazoles; Kidney Function Tests; Kidney Transplantation; Leflunomide; Time Factors | 1994 |
Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
Topics: Animals; Cricetinae; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Lew; Regression Analysis; Time Factors; Transplantation, Heterologous; Transplantation, Heterotopic | 1994 |
Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus, Experimental; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Male; Mice; Mice, Inbred BALB C; Tilapia; Transplantation, Heterologous | 1994 |
Oral leflunomide prevents small bowel allograft rejection in the rat.
Topics: Administration, Oral; Animals; Cyclosporine; Graft Rejection; Graft Survival; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Leflunomide; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1994 |
Promotion of corneal allograft survival with leflunomide.
Topics: Administration, Oral; Animals; Cornea; Cyclosporine; Female; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Keratoplasty, Penetrating; Leflunomide; Rats; Rats, Inbred Lew; Rats, Inbred WF; Transplantation, Homologous | 1994 |
Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
Topics: Abdomen; Acute Disease; Animals; Antibody Formation; Cyclosporine; Drug Therapy, Combination; Empyema; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoantibodies; Isoxazoles; Leflunomide; Male; Models, Biological; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Sprague-Dawley; Transplantation, Heterotopic | 1994 |
Elevated levels of TNF in the joints of adjuvant arthritic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Biological Assay; Cells, Cultured; Cyclosporine; Edema; Freund's Adjuvant; Ibuprofen; Isoxazoles; Joints; L Cells; Leflunomide; Macrophages, Peritoneal; Male; Methotrexate; Mice; Mycobacterium tuberculosis; Rabbits; Rats; Rats, Inbred Lew; Tumor Necrosis Factor-alpha | 1993 |
Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD28 Antigens; CD3 Complex; Cyclosporine; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Receptors, Interleukin-2; Tetradecanoylphorbol Acetate | 1993 |
Immunosuppressive effects of leflunomide in a cardiac allograft model.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Heterotopic; Transplantation, Homologous | 1993 |
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
Topics: Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Polyenes; Sirolimus; T-Lymphocytes; Thymidine; Tritium | 1993 |
Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immune Tolerance; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Rats; Rats, Inbred BN; Rats, Inbred F344; Rats, Inbred Strains; Skin Transplantation; Spleen; Time Factors; Transplantation, Homologous | 1993 |
Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
Topics: Animals; Antibodies, Heterophile; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Male; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Swine; Tacrolimus; Transplantation, Heterologous | 1995 |
Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions.
Topics: Animals; Antibody Formation; Cricetinae; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Transplantation, Heterologous | 1995 |
Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival.
Topics: Animals; Antibodies, Heterophile; Antigens, Heterophile; Cricetinae; Cyclosporine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Heterologous; Transplantation, Heterotopic | 1996 |
Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
Topics: Animals; Antibody Formation; Cricetinae; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Heterotopic | 1996 |
Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
Topics: Animals; Cricetinae; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Homologous | 1996 |
Effect of leflunomide, cyclosporine, and splenectomy in two different organ systems of concordant xenotransplantation in rats.
Topics: Animals; Combined Modality Therapy; Cricetinae; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Kidney Neoplasms; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Lew; Splenectomy; Transplantation, Heterologous | 1996 |
Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Cricetinae; Cyclosporine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Trachea; Transplantation, Heterologous | 1996 |
Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
Topics: Animals; Antibodies, Heterophile; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Graft Rejection; Immunoglobulin G; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1996 |
Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
Topics: Animals; Cyclosporine; Dogs; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Culture Test, Mixed; Transplantation, Homologous | 1996 |
Delayed xenograft rejection in the concordant hamster heart into Lewis rat model.
Topics: Acute Disease; Animals; Cricetinae; Cyclosporine; Drug Administration Schedule; Graft Rejection; Heart Transplantation; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Heterologous | 1996 |
Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
Topics: Animals; Antibodies, Monoclonal; CD4 Antigens; Cyclosporine; Drug Combinations; Flow Cytometry; Fluorescent Antibody Technique, Direct; Graft Rejection; Immune Tolerance; Immunosuppressive Agents; Isoxazoles; Keratoplasty, Penetrating; Leflunomide; Lymphocytes; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1996 |
Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.
Topics: Animals; Cyclosporine; Evoked Potentials; Graft Rejection; Graft Survival; Hindlimb; Immunosuppressive Agents; Isoxazoles; Leflunomide; Muscle, Skeletal; Nerve Regeneration; Neural Conduction; Neuromuscular Junction; Peripheral Nerves; Rats; Rats, Inbred BN; Rats, Inbred Lew; Skin Transplantation | 1996 |
Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin A.
Topics: Animals; Arthritis; Autoantibodies; Cyclosporine; Female; Immunosuppressive Agents; Isoxazoles; Leflunomide; Organ Size; Rats; Rats, Wistar; Serum Albumin, Bovine | 1996 |
Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
Topics: Animals; Cricetinae; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Heterologous | 1996 |
A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Polyenes; Rats; Rats, Inbred Strains; Sirolimus | 1996 |
Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
Topics: Alkynes; Animals; Cyclosporine; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Mice; Mice, Inbred BALB C; Nitriles; Rats; Rats, Inbred Lew; Skin Transplantation; Time Factors; Transplantation, Heterologous | 1996 |
Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
Topics: Acute Disease; Alkynes; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Skin Transplantation; Time Factors | 1996 |
In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies.
Topics: Animals; Antibody Formation; B-Lymphocytes; Cells, Cultured; Cyclosporine; Flow Cytometry; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; T-Lymphocytes | 1996 |
Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Polyenes; Rats; Rats, Inbred Strains; Sirolimus; T-Lymphocytes; Time Factors; Transplantation, Homologous | 1996 |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.
Topics: Animals; Body Weight; Cyclosporine; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Rats; Tacrolimus; Time Factors | 1997 |
Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model.
Topics: Animals; Antibodies; Complement System Proteins; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Immunoglobulin G; Immunohistochemistry; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Male; Mice; Pregnancy; Rats; Swine; Time Factors; Transplantation, Heterologous; Uridine | 1997 |
Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugs.
Topics: Animals; C-Reactive Protein; Cyclosporine; Drug Evaluation, Preclinical; Female; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunosuppressive Agents; Indomethacin; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C | 1997 |
Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Rats; Rats, Sprague-Dawley; Species Specificity; Transplantation, Heterologous | 1997 |
Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine.
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Swine; Transplantation, Heterologous | 1997 |
Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Haplorhini; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1997 |
Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts.
Topics: Animals; Antibody Formation; Antibody Specificity; Cricetinae; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Homologous | 1997 |
Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hindlimb; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Peroneal Nerve; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sensation; Transplantation, Homologous; Transplantation, Isogeneic; Weight-Bearing | 1997 |
Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
Topics: Alkynes; Animals; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Mice; Mice, Inbred BALB C; Nitriles; Rats; Rats, Inbred Lew; Skin Transplantation; Time Factors; Transplantation, Heterologous | 1997 |
Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts.
Topics: Animals; Antibody Formation; Complement C3; Cricetinae; Cyclosporine; Graft Rejection; Heart Transplantation; Immunoglobulin M; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred Lew; T-Lymphocytes; Time Factors | 1997 |
Blockade of induced xenoantigen expression prevents rejection after retransplantation of accommodated hamster-to-rat heart xenografts.
Topics: Animals; Antibodies, Heterophile; Antigens, Heterophile; Cells, Cultured; Cricetinae; Cyclosporine; E-Selectin; Endothelium, Vascular; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunoglobulin M; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Leflunomide; Male; Mesocricetus; P-Selectin; Rats; Rats, Inbred Strains; Reoperation; Time Factors; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 1998 |
Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
Topics: Alkynes; Animals; Antibody Formation; Cyclosporine; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Mice; Mice, Inbred BALB C; Nitriles; Rats; Rats, Inbred Lew; Skin Transplantation; Transplantation, Heterologous | 1997 |
The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in the rat.
Topics: Animals; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Wistar | 1998 |
Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts.
Topics: Adoptive Transfer; Animals; Antibody Formation; Antigens, T-Independent; B-Lymphocytes; Complement C6; Cricetinae; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immune Tolerance; Immunoglobulin M; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Rats; Rats, Inbred Strains; T-Lymphocytes; Time Factors; Transplantation, Heterologous | 1998 |
Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data.
Topics: Anticonvulsants; Cyclosporine; Cytochrome P-450 Enzyme System; Dihydroergotamine; Drug Interactions; Humans; In Vitro Techniques; Isoxazoles; Itraconazole; Ketoconazole; Metabolic Clearance Rate; Miconazole; Triazolam; Zonisamide | 1998 |
Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
Topics: Acute Disease; Alkynes; Animals; Antibodies, Heterophile; Antibody Formation; Cyclosporine; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Mice; Mice, Inbred BALB C; Nitriles; Rats; Rats, Inbred Lew; Skin Transplantation; Time Factors; Transplantation, Heterologous | 1998 |
Effect of leflunomide and cyclosporine on graft survival and changes in lymphocyte phenotypes in a rat heart allotransplantation model.
Topics: Animals; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Cyclosporine; Graft Survival; Heart Transplantation; Immunophenotyping; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous | 1998 |
Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival.
Topics: Alkynes; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Graft Rejection; Graft Survival; Heart Transplantation; Immune Tolerance; Immunosuppressive Agents; Isoxazoles; Male; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew; Species Specificity; Time Factors | 1998 |
Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
Topics: Acute Disease; Alkynes; Animals; Cyclosporine; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred F344; Rats, Inbred Lew; Skin Transplantation | 1998 |
Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
Topics: Acute Disease; Animals; Cricetinae; Cyclosporine; Disease Models, Animal; Drug Combinations; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Rats; Rats, Inbred Lew; Species Specificity; Time Factors; Transplantation, Heterologous | 1998 |
Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
Topics: Animals; Chronic Disease; Cricetinae; Cyclosporine; Disease Models, Animal; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Myocardium; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterologous | 1998 |
Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
Topics: Alkynes; Animals; Antibody Specificity; Autoantibodies; Cyclosporine; Drug Synergism; Graft Rejection; Heart Transplantation; Immunization; Immunosuppressive Agents; Isoxazoles; Male; Myocardium; Nitriles; Rats; Rats, Inbred Strains | 1998 |
Malononitrilamides 715 and 279 prolong rat cardiac allograft survival, reverse ongoing rejection, inhibit allospecific antibody production and interact positively with cyclosporin.
Topics: Alkynes; Aniline Compounds; Animals; Antibody Formation; Crotonates; Cyclosporine; Drug Interactions; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hydroxybutyrates; Immunoglobulin Allotypes; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred Strains; Toluidines; Transplantation, Homologous | 1998 |
Irradiation or temporal variations in immunosuppressive schedules do not prevent graft-versus-host disease following rat limb allotransplantation.
Topics: Animals; Cyclosporine; Drug Administration Schedule; Extremities; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1998 |
Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
Topics: Amides; Aniline Compounds; Animals; Biotransformation; Body Weight; Chromatography, High Pressure Liquid; Crotonates; Cyclosporine; Drug Therapy, Combination; Emulsions; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Transplantation; Male; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew; Structure-Activity Relationship; Toluidines | 1999 |
Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay.
Topics: Acrylamides; Alkynes; Aniline Compounds; Animals; Biphenyl Compounds; Caproates; Crotonates; Cyclosporine; Dose-Response Relationship, Drug; Flow Cytometry; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphocytes; Male; Nitriles; Rats; Rats, Inbred Lew; Receptors, Interleukin-2; Receptors, OX40; Receptors, Tumor Necrosis Factor; Toluidines; Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1999 |
Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model.
Topics: Alkynes; Animals; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Mycophenolic Acid; Nitriles; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2000 |
Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Topics: Animals; Blood Glucose; Cyclosporine; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2000 |
Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
Topics: Animals; Cats; Cell Division; Coloring Agents; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Inhibitory Concentration 50; Isoxazoles; Leflunomide; Lymphocyte Activation; Mycophenolic Acid; Pokeweed Mitogens; Scintillation Counting; Sirolimus; Tacrolimus; Trypan Blue | 2000 |
The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.
Topics: Actin Depolymerizing Factors; Cyclosporine; Dexamethasone; Humans; Isoxazoles; Leflunomide; Microfilament Proteins; Mycophenolic Acid; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Sirolimus; T-Lymphocytes; Tacrolimus | 2000 |
The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation.
Topics: Animals; Body Weight; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Tacrolimus; Time Factors; Transplantation, Homologous | 1994 |
Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Topics: Animals; Antibodies, Heterophile; Blood Glucose; C-Peptide; Cell Culture Techniques; Cell Separation; Cyclosporine; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Female; Graft Survival; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Macrophages; Mice; Mice, Nude; Mycophenolic Acid; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 2001 |
Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
Topics: Alkynes; Animals; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred NOD; Nitriles; Rats; Transplantation, Heterologous | 2001 |
Efficacy of malononitrilamide 715 as immunosuppressant, alone or in combination with cyclosporin, in allogeneic foetal rat pancreatic transplantation.
Topics: Alkynes; Animals; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Immunosuppressive Agents; Isoxazoles; Nitriles; Pancreas Transplantation; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Subrenal Capsule Assay; T-Lymphocytes; Transplantation, Homologous; Weight Gain; Weight Loss | 2001 |
Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
Topics: Aniline Compounds; Animals; Antigens, Heterophile; B-Lymphocytes; Biphenyl Compounds; Cell Division; Crotonates; Cyclosporine; Drug Resistance; Graft Rejection; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphoma, B-Cell; Mycophenolic Acid; Nitriles; Primates; Pyrazoles; Swine; T-Lymphocytes; Toluidines; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Conventional DMARD options for patients with a suboptimal response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
Topics: Adult; Blood Sedimentation; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pilot Projects; Retrospective Studies | 2001 |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Cyclosporine; Endothelium, Vascular; Humans; Isoxazoles; Leflunomide; Mice; Microcirculation; Models, Animal; Tacrolimus; Umbilical Veins; Uridine | 2001 |
A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs.
Topics: Alkynes; Animals; Cyclosporine; Dogs; Female; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Nitriles; Tacrolimus | 2002 |
Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process.
Topics: Actins; Animals; Anti-Inflammatory Agents; Antibodies, Heterophile; Cyclosporine; Female; Fetal Tissue Transplantation; Graft Rejection; Guanidines; Immunosuppressive Agents; Interleukins; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Male; Prednisolone; Pregnancy; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Tacrolimus; Transplantation, Heterologous | 2002 |
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors | 2003 |
Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
Topics: Alkynes; Animals; Cyclosporine; Dogs; Drug Therapy, Combination; Emulsions; Graft Survival; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Nitriles; Osmolar Concentration | 2003 |
Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy.
Topics: Animals; Antibodies, Heterophile; Aorta; Cricetinae; Cyclosporine; Drug Therapy, Combination; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Rats; Rats, Inbred Lew; Rats, Nude; Tissue and Organ Harvesting; Transplantation, Heterologous | 2004 |
[When to begin rheumatism treatment? Initial combination therapy helps fastest].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
[Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Toward the definition of immunosuppressive regimens with antitumor activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Jurkat Cells; Leflunomide; Liver Neoplasms; Mycophenolic Acid; Rhabdomyosarcoma; Sirolimus | 2005 |
P-glycoprotein interaction with risperidone and 9-OH-risperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Brain; Cyclosporine; Drug Interactions; In Vitro Techniques; Isoxazoles; Liver; Mass Spectrometry; Mice; Mice, Knockout; Nortriptyline; Paliperidone Palmitate; Pyrimidines | 2005 |
The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
Topics: Alkynes; Animals; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Nitriles; Platelet-Derived Growth Factor; Rats; Rats, Inbred Strains; Rats, Inbred WF; Tacrolimus; Transforming Growth Factor beta; Transplantation, Homologous | 2006 |
The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Topics: Alkynes; Animals; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Nitriles; Rats; Rats, Inbred WF; Tacrolimus; Transforming Growth Factor beta; Transplantation, Homologous; Transplantation, Isogeneic | 2006 |
Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
Topics: Alkynes; Animals; Aorta; Aortic Diseases; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Isoxazoles; Male; Nitriles; Rats; Rats, Inbred ACI; Transplantation, Homologous | 2008 |
[Psoriatic arthritis].
Topics: Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis | 2008 |
FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Topics: Alkynes; Animals; Calcineurin Inhibitors; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Male; Nitriles; Platelet-Derived Growth Factor; Rats; Rats, Inbred WF; Risk Factors; Tacrolimus; Transforming Growth Factor beta; Transplantation, Homologous | 2008 |
The effects of PDTC plus leflunomide and cyclosporine on the NF-kappaB signaling pathway in mouse-to-rat cardiac xenografts.
Topics: Animals; Cyclosporine; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mice; NF-kappa B; Pyrrolidines; Rats; Rats, Wistar; Signal Transduction; Thiocarbamates; Transplantation, Heterologous | 2009 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs.
Topics: Adult; Aged; BK Virus; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Isoxazoles; Kidney Transplantation; Leflunomide; Middle Aged; Mycophenolic Acid; Polyomavirus Infections; Reference Values; T-Lymphocytes; Tacrolimus | 2009 |
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine | 2010 |
Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Survival; Chenodeoxycholic Acid; Cyclosporine; Cytochromes c; Enzyme Inhibitors; Isoxazoles; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pregnenediones; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering | 2013 |
Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; Cell Count; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immune Tolerance; Immunity; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Isoxazoles; Leflunomide; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Mycophenolic Acid; Ovalbumin; Propylene Glycols; Sirolimus; Sphingosine; Spleen; T-Lymphocytes, Regulatory | 2012 |
Synthesis and immunomodulation of human lymphocyte proliferation and cytokine (interferon-γ) production of four novel leflunomide analogues.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Factors; Interferon-gamma; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphocytes; Structure-Activity Relationship | 2012 |
In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.
Topics: Aniline Compounds; Animals; Azathioprine; Cell Proliferation; Crotonates; Cyclosporine; Dexamethasone; Dogs; Flow Cytometry; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Nitriles; T-Lymphocytes; Toluidines | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Fumarates; Germany; Humans; Infliximab; Isoxazoles; Keratolytic Agents; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Psoriasis; Retrospective Studies | 2015 |
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Biological Factors; Causality; Cohort Studies; Comorbidity; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Herpes Zoster; Herpes Zoster Vaccine; Humans; Incidence; Isoxazoles; Male; Methotrexate; Middle Aged; Multivariate Analysis; Phototherapy; Psoriasis; Risk Factors; Sex Distribution; Ustekinumab | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
[Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Topics: Animals; Autoimmune Diseases; Cyclosporine; Down-Regulation; Eye Proteins; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Isoxazoles; Leflunomide; Random Allocation; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; RNA, Messenger; Th17 Cells; Uveitis | 2015 |
Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Diagnosis, Differential; Hair Diseases; Hair Follicle; Humans; Immunologic Factors; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver Transplantation; Male; Polyomavirus Infections; Pruritus | 2017 |